𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro–in vivo correlation of modified release dosage form of lamotrigine

✍ Scribed by Hiten J. Shah; Gunta Subbaiah; Dasharath M. Patel; Chhagan N. Patel


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
158 KB
Volume
30
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Application of in vitro–in vivo correlat
✍ Nishit B. Modi; Andrew Lam; Elizabeth Lindemulder; Bei Wang; Suneel K. Gupta 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract An __in vitro__–__in vivo__ correlation (IVIVC) was established for an osmotic controlled‐release dosage form by deconvolution using data from an immediate‐release treatment as the characteristic response. The established IVIVC was evaluated internally (predicting data used to develop t

Gastrointestinal bioavailability: Determ
✍ William R. Gillespie; Peter Veng-Pedersen 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

If a linear relationship exists between the rate of drug release or dissolution in the gastrointestinal tract, f ( t ) , and the resulting systemic drug level, c(t), that relationship can be expressed as a convolution: where c&) is the systemic drug concentration resulting from the instantaneous in

Bioequivalence study of nalidixic acid t
✍ H. Jung; H. Gonzalez; J. M. Rodriguez 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

The USP dissolution test was used to select seven products with a wide range of dissolution characteristics for in vivo examination. The bioequivalence of seven (500 mg) products was evaluated in two crossover urinary excretion experiments. In each study three products were compared with the innovat

Pharmacokinetic evaluation of novel sust
✍ Meir Bialer; Michael Friedman; Joseph Dubrovsky; Itamar Raz; Oded Abramsky 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

1. Five new sustained-release dosage forms of valproic acid (VPA) were developed. 2. The new sustained-release formulations were administered to six healthy subjects for comparison with a standard tablet and an i.v. preparation of the drug. 3. Three of the formulations exhibited a more prolonged and